DK264687A - Substituerede 6-hydroxymethyl-carbapenem-antibiotika, deres fremstilling og anvendelse - Google Patents

Substituerede 6-hydroxymethyl-carbapenem-antibiotika, deres fremstilling og anvendelse

Info

Publication number
DK264687A
DK264687A DK264687A DK264687A DK264687A DK 264687 A DK264687 A DK 264687A DK 264687 A DK264687 A DK 264687A DK 264687 A DK264687 A DK 264687A DK 264687 A DK264687 A DK 264687A
Authority
DK
Denmark
Prior art keywords
hydroxymethyl
substituted
preparation
image
carbapenem antibiotics
Prior art date
Application number
DK264687A
Other languages
English (en)
Other versions
DK264687D0 (da
Inventor
Dieter Haebich
Wolfgang Hartwig
Karl Georg Metzger
Hans-Joacim Zeiler
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK264687D0 publication Critical patent/DK264687D0/da
Publication of DK264687A publication Critical patent/DK264687A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
DK264687A 1986-05-26 1987-05-25 Substituerede 6-hydroxymethyl-carbapenem-antibiotika, deres fremstilling og anvendelse DK264687A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863617626 DE3617626A1 (de) 1986-05-26 1986-05-26 Substituierte 6-hydroxymethyl-carbapenem-antibiotika, verfahren zu ihrer herstellung und ihre verwendung

Publications (2)

Publication Number Publication Date
DK264687D0 DK264687D0 (da) 1987-05-25
DK264687A true DK264687A (da) 1987-11-27

Family

ID=6301640

Family Applications (1)

Application Number Title Priority Date Filing Date
DK264687A DK264687A (da) 1986-05-26 1987-05-25 Substituerede 6-hydroxymethyl-carbapenem-antibiotika, deres fremstilling og anvendelse

Country Status (12)

Country Link
US (1) US4863916A (da)
EP (1) EP0247431B1 (da)
JP (1) JPS62283974A (da)
KR (1) KR870011139A (da)
AT (1) ATE55132T1 (da)
AU (1) AU7319087A (da)
DE (2) DE3617626A1 (da)
DK (1) DK264687A (da)
FI (1) FI872265A (da)
HU (1) HU197009B (da)
IL (1) IL82629A0 (da)
ZA (1) ZA873721B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6425779A (en) * 1987-04-11 1989-01-27 Lederle Japan Ltd (1r,5s,6s)-2-substituted-thio-6-((r)-1-hydroxyethyl)-1-methyl -carbapenem-3-carboxylic acid derivative
JP2003277390A (ja) * 2002-03-25 2003-10-02 Takasago Internatl Corp アゼチジノン化合物の製造方法
KR100599876B1 (ko) * 2004-08-31 2006-07-13 한국화학연구원 2-아릴메틸아제티딘 카바페넴 유도체 및 그의 제조방법
ES2477884T3 (es) 2008-08-19 2014-07-18 Xenoport, Inc. Profármacos de hidrogenofumarato de metilo, composiciones farmacéuticas de los mismos y procedimientos de uso
CA2882713A1 (en) 2012-08-22 2014-02-27 Xenoport, Inc. Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects
WO2014031897A1 (en) 2012-08-22 2014-02-27 Xenoport, Inc. Oral dosage forms having a high loading of (n,n- diethylcarbamoyl)methyl methyl|(2e)but-2-ene-1,4-dioate
WO2014160633A1 (en) 2013-03-24 2014-10-02 Xenoport, Inc. Pharmaceutical compositions of dimethyl fumarate
CN104211666B (zh) 2013-05-31 2017-11-14 中国人民解放军军事医学科学院毒物药物研究所 2,3‑环氧丁二酰胺类化合物、其制备方法和用途
WO2014197860A1 (en) 2013-06-07 2014-12-11 Xenoport, Inc. Method of making monomethyl fumarate
US9421182B2 (en) 2013-06-21 2016-08-23 Xenoport, Inc. Cocrystals of dimethyl fumarate
TW201516020A (zh) 2013-09-06 2015-05-01 Xenoport Inc （ｎ，ｎ－二乙基胺甲醯基）甲基（２ｅ）丁－２－烯－１，４－二酸甲酯之晶形、合成方法及用途
US9999672B2 (en) 2014-03-24 2018-06-19 Xenoport, Inc. Pharmaceutical compositions of fumaric acid esters

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0017992A1 (en) * 1979-04-19 1980-10-29 Merck & Co. Inc. 2-Substituted-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids, processes for preparing them, antibiotic pharmaceutical compositions containing same and process for preparing intermediates
US4590073A (en) * 1984-10-22 1986-05-20 Pfizer Inc. 6-substituted penicillanic acid 1,1-dioxide compounds

Also Published As

Publication number Publication date
FI872265A0 (fi) 1987-05-22
AU7319087A (en) 1987-12-03
IL82629A0 (en) 1987-11-30
DK264687D0 (da) 1987-05-25
EP0247431A1 (de) 1987-12-02
DE3617626A1 (de) 1987-12-03
US4863916A (en) 1989-09-05
ZA873721B (en) 1987-11-20
EP0247431B1 (de) 1990-08-01
ATE55132T1 (de) 1990-08-15
HU197009B (en) 1989-02-28
KR870011139A (ko) 1987-12-21
FI872265A (fi) 1987-11-27
DE3764027D1 (de) 1990-09-06
HUT45058A (en) 1988-05-30
JPS62283974A (ja) 1987-12-09

Similar Documents

Publication Publication Date Title
DE69132435D1 (de) Inhibitoren retroviraler Proteasen
NO872784D0 (no) Fremgangsmaate til fremstilling av substituerte amino-5,6,7,8-tetrahydronaftyl-oksyeddiksyrer.
DK383688A (da) 3-desmethyl-mevalonsyrederivater, deres fremstilling og anvendelse samt mellemprodukter ved fremstilling
DK264687D0 (da) Substituerede 6-hydroxymethyl-carbapenem-antibiotika, deres fremstilling og anvendelse
ATE28076T1 (de) Verfahren zur herstellung von tetrahydropyridinen.
FI892675A0 (fi) 2,6-dihalogenpyridin-3 -karboxylsyraderivat och deras framstaellning.
NO855342L (no) Pyridoyrimidiner og fremgangsmaater for fremstilling derav.
ES541780A0 (es) Tetrahidrotienopiridinas
FI874123A0 (fi) Heptanoyl-glu-asp-ala-aminosyra -immunostimulanter.
ES543301A0 (es) Cefalosporinas
DK422688A (da) Substituerede pyridylethanolaminer og fysiologisk acceptable salte og n-oxider deraf, deres fremstilling og anvendelse samt mellemprodukter og disses fremstilling
ATE35134T1 (de) Beta-naphthylalkylamine.
LV10153A (lv) Sastavs seklu dezinfekcijai
FI870067A (fi) Metionin-substituerade 1,4-dihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning.
ATE24906T1 (de) Pyrazolidinedion-derivate mit gefaesserweiternder, antiaggregationer und hypocholesterolemischer wirkung.
DK420187D0 (da) Oxiran-pseudooligosaccharider, deres fremstilling og anvendelse
FI821141A0 (fi) 5,6-dihydro-11-alkylen-morfantridin-6-one, deras framstaellning och dessa innehaollande laekemedel
GR1000138B (el) Νεα παραγωγα ριβοφουρανουρονικου οξεος, μεθοδος δια την παρασευη αυτων και η χρησιμοποιησις αυτων.

Legal Events

Date Code Title Description
ATS Application withdrawn